[Blood coagulation in extracorporeal circulation].
D000328:Adult; D000933:Antifibrinolytic Agents / Q000008:administration & dosage; D007611:Aprotinin / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology*; D001791:Blood Platelet Disorders / Q000139:chemically induced / Q000209:etiology; D006348:Cardiac Surgical Procedures / Q000009:adverse effects; D002648:Child; D003490:Cyanosis; D005112:Extracorporeal Circulation; D006400:Hematocrit; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007022:Hypotension; D007263:Infusions, Parenteral; D011183:Postoperative Complications; D011479:Protamines / Q000008:administration & dosage; D013997:Time Factors
D000933:Antifibrinolytic Agents; D011479:Protamines; D006493:Heparin; D007611:Aprotinin
Die Blutgerinnung im extrakorporalen Kreislauf.